- Home
- CIGL vs PMVP Comparison
CIGL vs PMVP Comparison
Compare CIGL & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CIGL | PMVP |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.4M | 66.0M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CIGL | PMVP |
|---|---|---|
| Price | $1.72 | $1.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 20.9K | ★ 231.9K |
| Earning Date | 09-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,072,733.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.32 | N/A |
| 52 Week Low | $1.40 | $0.81 |
| 52 Week High | $31.06 | $1.84 |
Technical Indicators
Market Signals| Indicator | CIGL | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 48.76 |
| Support Level | $1.55 | $1.20 |
| Resistance Level | $1.94 | $1.27 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 56.10 | 72.22 |
Price Performance
Historical ComparisonAbout CIGL Concorde International Group Ltd Class A Ordinary Shares
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.